This move is archived. Current quotes and coverage live on the stock page.
Get BCT alerts:
Briacell Therapeutics Corp (BCT.TO) is seeing a significant rise in its stock price, closing up 4.31% in the latest trading session. Investors are showing renewed interest, with the stock surging to CA$4.84. This positive trend comes amid strategic developments within the company that could strengthen its market position.
Investor takeaway: For Canadian investors, Briacell Therapeutics offers a potential growth opportunity, especially in the biotech sector, where advancements in treatment options can boost stock performance.
Briacell Therapeutics Corp Up 4.31% in One Day
Advertisement
Briacell Therapeutics Corp
BCT.TO
BCT.TO
Briacell Therapeutics Corp
WealthAwesomeMarket cap
$43.32M
52W high
$20.40
52W low
$3.68
1W change
-1.39%
Beta
1.53
Analyst Price Targets
Based on analyst covering BCT · as of Sep 17, 2026
Wall Street analysts forecast BCT stock price to rise 301.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.00
+301.6% Upside
Current Price
C$4.98
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BCT's historical volatility
30-Day Vol
91.8%
Annualized
90-Day Vol
91.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$7.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$6.28 | C$4.58 – C$8.62 |
| 60 trading days | C$6.67 | C$4.26 – C$10.44 |
| 90 trading days | C$7.08 | C$4.09 – C$12.25 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
With a market cap of CA$41.8 million, Briacell's stock performance indicates strong interest in its innovative cancer treatment approaches.
Bull case
The recent rise in Briacell's stock price shows growing investor confidence. This optimism may stem from the company’s ongoing advancements in cancer treatment and successful fundraising efforts, which could signal a promising future.
Bear case
Despite the positive movement, investors should stay cautious. The biotech sector can be unpredictable, and the lack of consistent profitability may present risks.
Recent Performance Overview
Briacell Therapeutics Corp's stock has increased notably, closing at CA$4.84 after gaining 4.31% in the last trading session. This uptick likely results from a mix of strategic initiatives and investor confidence in the company's future prospects.
Advertisement
Market Reactions and Investor Sentiment
The rise in Briacell's stock price reflects a broader trend of optimism in the biotech sector, especially as the company continues to develop innovative cancer therapies. This positive sentiment is important for potential investors considering entering the market.
Looking Ahead: What’s Next for Briacell?
As Briacell Therapeutics moves forward, investors will closely watch for updates on clinical trials and potential partnerships. The company's commitment to advancing its treatments could lead to further stock price appreciation, making it a stock to keep an eye on in the coming days.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
